Albumin in Normovolemic Fluid Management for Severe Traumatic Brain Injury: Controversies and Research Gaps
Journal of Clinical Medicine · 13.09.2024 · 13 (18) · 5452
DOI: 10.3390/jcm13185452 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.09.2024. Verfasst von Christian J Wiedermann. Beteiligte Einrichtung: Institute of General Practice and Public Health, Claudiana-College of Health Professions, 39100 Bolzano, Italy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Traumatic brain injury (TBI) is a significant public health issue characterized by high mortality rates and long-term complications. This commentary examines the controversial role of the use of albumin in the fluid management of patients with severe TBI. Despite its physiological benefits, the clinical use of albumin remains controversial due to the fact that various studies have yielded mixed results. Serum albumin is important for maintaining normovolemia, primarily through its contribution to colloid osmotic pressure, which helps to retain fluid in the circulatory system. This review highlights the existing evidence, examines inconsistencies in guideline recommendations, and suggests future research directions to clarify the efficacy and safety of the use of albumin in maintaining normovolemia in patients with TBI. The review also discusses the potential benefits of small-volume resuscitation strategies for the management of acute kidney injury in TBI patients, drawing parallels with the management of septic acute kidney injury. The need for further well-designed randomized controlled trials and ethical considerations in studies regarding the use of hyperoncotic albumin in TBI management is emphasized.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of General Practice and Public Health, Claudiana-College of Health Professions, 39100 Bolzano, Italy.
- Department of Public Health, Medical Decision Making and Health Technology Assessment, UMIT TIROL-Private University for Health Sciences and Health Technology, 6060 Hall, Austria.
ORCID-Profile: Christian J Wiedermann
Zitieren
APA
Wiedermann, C. J. (2024). Albumin in Normovolemic Fluid Management for Severe Traumatic Brain Injury: Controversies and Research Gaps. Journal of Clinical Medicine, 13(18), 5452. https://doi.org/10.3390/jcm13185452
Vancouver
Wiedermann CJ. Albumin in Normovolemic Fluid Management for Severe Traumatic Brain Injury: Controversies and Research Gaps. Journal of Clinical Medicine. 2024;13(18):5452. doi:10.3390/jcm13185452
BibTeX
@article{Wiedermann2024,
author = {Wiedermann, Christian J},
title = {Albumin in Normovolemic Fluid Management for Severe Traumatic Brain Injury: Controversies and Research Gaps},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {18},
pages = {5452},
doi = {10.3390/jcm13185452}
}
EUVIMED